Carlsmed (CARL) Accounts Payables (2024 - 2026)

Carlsmed (CARL) has reported Accounts Payables for 3 consecutive years, with $3.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Accounts Payables rose 43.51% year-over-year to $3.7 million; the trailing twelve-month figure through Jun 2026 stood at $3.7 million (up 43.51% YoY), and the FY2025 full-year result was $4.5 million, up 85.78% from the prior year.
• Accounts Payables climbed to $3.7 million in Q2 2026 per CARL's latest filing, from $3.0 million in the prior quarter.
• Across five years, Accounts Payables topped out at $4.5 million in Q4 2025 and bottomed at $2.4 million in Q4 2024.
• Historically, Accounts Payables has averaged $3.1 million across 3 years, with a median of $2.8 million in 2025.
• The sharpest annual moves came in 2025 and 2026: Accounts Payables surged 85.78% in 2025, then surged 43.51% in 2026.
• Over 3 years, Accounts Payables stood at $2.4 million in 2024, then soared by 85.78% to $4.5 million in 2025, then dropped by 17.34% to $3.7 million in 2026.
• According to Business Quant data, Accounts Payables over the past three periods registered $3.7 million, $3.0 million, and $4.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.